T. Rowe Price Investment Management Portfolio holdings
T. Rowe Price Investment Management, Inc. (TRPIM), a division of T. Rowe Price Group established in August 2022 and headquartered in Baltimore, Maryland, is an active investment manager overseeing hundreds of billions in assets, focusing on equity and fixed-income strategies for institutional clients and sub-advisory mandates. Spun off from the parent company founded in 1937 by Thomas Rowe Price, Jr., TRPIM operates as a distinct entity with around 900 employees, emphasizing a research-driven, long-term approach rooted in fundamental analysis and disciplined risk management. Managing portfolios like large-cap growth and international equity funds, it complements T. Rowe Price’s broader offerings while targeting sophisticated investors such as pension funds and endowments with tailored, high-conviction solutions. Under the leadership of president Rob Sharps, TRPIM upholds the firm’s legacy of integrity and client focus, adapting its founder’s value-oriented philosophy to modern institutional needs.
Top Buys
| 1 |
McKesson
MCK
|
$1.1B |
| 2 |
Advanced Micro Devices
AMD
|
$673M |
| 3 |
Service Corp International
SCI
|
$664M |
| 4 |
NVIDIA
NVDA
|
$638M |
| 5 |
NXP Semiconductors
NXPI
|
$601M |
Top Sells
| 1 |
Waste Connections
WCN
|
$1.12B |
| 2 |
Exelon
EXC
|
$862M |
| 3 |
Veralto
VLTO
|
$772M |
| 4 |
Intercontinental Exchange
ICE
|
$730M |
| 5 |
Intuit
INTU
|
$708M |
Sector Composition
| 1 | Technology | 25.1% |
| 2 | Healthcare | 21.6% |
| 3 | Consumer Discretionary | 12.25% |
| 4 | Industrials | 10.78% |
| 5 | Financials | 10.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
Reddit
RDDT
$43.4B
| $267M | 0.16% |
4,049,268
+2,402,200
| +146% | +$158M |
|
152
Ascendis Pharma
ASND
$12B
| $264M | 0.16% |
1,765,042
+1,734,478
| +5,675% | +$259M |
|
153
Treehouse Foods
THS
$917M
| $257M | 0.16% |
6,125,550
-1,254,024
| -17% | -$52.6M |
|
154
FirstService
FSV
$9.2B
| $257M | 0.15% |
1,407,893
-178,420
| -11% | -$32.6M |
|
|
155
Exelon
EXC
$43.8B
| $256M | 0.15% |
6,313,261
-21,253,751
| -77% | -$862M |
|
156
Constellium
CSTM
$1.95B
| $254M | 0.15% |
15,646,915
+1,625,657
| +12% | +$26.4M |
|
157
West Pharmaceutical
WST
$17.8B
| $252M | 0.15% |
839,310
-282,675
| -25% | -$84.8M |
|
158
Reynolds Consumer Products
REYN
$4.96B
| $250M | 0.15% |
8,048,368
-72,540
| -0.9% | -$2.26M |
|
159
McCormick & Company Non-Voting
MKC
$18.8B
| $249M | 0.15% |
3,024,174
+129,745
| +4% | +$10.7M |
|
160
Cognex
CGNX
$7.43B
| $249M | 0.15% |
6,137,424
-64,541
| -1% | -$2.61M |
|
161
Oscar Health
OSCR
$4.75B
| $247M | 0.15% |
11,661,066
+375,471
| +3% | +$7.96M |
|
162
Quanta Services
PWR
$56B
| $244M | 0.15% |
817,390
-5,500
| -0.7% | -$1.64M |
|
163
Sarepta Therapeutics
SRPT
$1.93B
| $243M | 0.15% |
1,946,240
-12,395
| -0.6% | -$1.55M |
|
164
Markel Group
MKL
$24.8B
| $243M | 0.15% |
154,720
+660
| +0.4% | +$1.04M |
|
165
Texas Capital Bancshares
TCBI
$3.99B
| $234M | 0.14% |
3,277,403
+382,171
| +13% | +$27.3M |
|
166
Exact Sciences
EXAS
$9.73B
| $231M | 0.14% |
3,392,838
+451,636
| +15% | +$30.8M |
|
167
Popular Inc
BPOP
$8.59B
| $230M | 0.14% |
2,292,719
-329,162
| -13% | -$33M |
|
168
Haemonetics
HAE
$2.61B
| $229M | 0.14% |
2,850,637
+1,207,696
| +74% | +$97.1M |
|
169
SiteOne Landscape Supply
SITE
$6.57B
| $227M | 0.14% |
1,506,286
+337,648
| +29% | +$51M |
|
170
Home BancShares
HOMB
$5.93B
| $226M | 0.14% |
8,360,690
+77,073
| +0.9% | +$2.09M |
|
171
Magnolia Oil & Gas
MGY
$4.56B
| $226M | 0.14% |
9,266,621
-493,005
| -5% | -$12M |
|
172
Houlihan Lokey
HLI
$13.9B
| $224M | 0.14% |
1,419,908
-11,129
| -0.8% | -$1.76M |
|
173
Strategic Education
STRA
$1.98B
| $223M | 0.13% |
2,413,089
-163,940
| -6% | -$15.2M |
|
174
Mirion Technologies
MIR
$4.84B
| $223M | 0.13% |
20,171,888
+190,277
| +1% | +$2.11M |
|
175
Matador Resources
MTDR
$6.22B
| $221M | 0.13% |
4,463,029
-321,873
| -7% | -$15.9M |
|